Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125663952 | 12566395 | 2 | F | 20160326 | 20160922 | 20160718 | 20160928 | EXP | FR-PFIZER INC-2016337274 | PFIZER | 84.00 | YR | F | Y | 0.00000 | 20160928 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125663952 | 12566395 | 1 | PS | Amlor | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY | Y | 19787 | 10 | MG | CAPSULE, HARD | QD | |||||
125663952 | 12566395 | 2 | SS | FLUDEX /00340101/ | INDAPAMIDE | 1 | Oral | 1.5 MG, 1X/DAY | Y | 0 | 1.5 | MG | PROLONGED-RELEASE TABLET | QD | |||||
125663952 | 12566395 | 3 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 50 MG, 1X/DAY | Y | 0 | 50 | MG | QD | ||||||
125663952 | 12566395 | 4 | SS | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | Oral | 1 DF, 2X/DAY | Y | 0 | 1 | DF | BID | ||||||
125663952 | 12566395 | 5 | SS | VALSARTAN. | VALSARTAN | 1 | Oral | 160 MG, 1X/DAY | Y | 0 | 160 | MG | QD | ||||||
125663952 | 12566395 | 6 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 12.5 MG, DAILY | Y | 0 | 12.5 | MG | |||||||
125663952 | 12566395 | 7 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
125663952 | 12566395 | 8 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
125663952 | 12566395 | 9 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
125663952 | 12566395 | 10 | C | OXYBUTYNINE | OXYBUTYNIN CHLORIDE | 1 | 1 DF, DAILY | 0 | 1 | DF | |||||||||
125663952 | 12566395 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
125663952 | 12566395 | 12 | C | DUOTRAV | TIMOLOL MALEATETRAVOPROST | 1 | 0 | EYE DROPS | |||||||||||
125663952 | 12566395 | 13 | C | AZOPT | BRINZOLAMIDE | 1 | 0 | EYE DROPS |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125663952 | 12566395 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125663952 | 12566395 | Acute kidney injury | |
125663952 | 12566395 | Orthostatic hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125663952 | 12566395 | 1 | 20160327 | 0 | ||
125663952 | 12566395 | 2 | 20160327 | 0 | ||
125663952 | 12566395 | 3 | 20160327 | 0 | ||
125663952 | 12566395 | 4 | 20160327 | 0 | ||
125663952 | 12566395 | 5 | 20160327 | 0 | ||
125663952 | 12566395 | 6 | 20160327 | 0 |